Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × senaparib × Clear all

NCT04089189 2026-01-28

SABRINA

Phase 2 Completed

Ovarian Neoplasms

NCT06617923 2025-10-27

Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer

Phase 2 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms